Repeated use of ClotHound in pig veins and arteries showed no significant damage to the vessel lining, even with the spheres opened 20-40% wider than the vessel.
Spheres expanded beyond the native vessel diameter, with no significant harm to the tested arteries and veins.
Five back-and-forth passes left the vessel walls intact on histology.
In the lung-artery model: complete removal in the first pig; in the second, about 80% on the first pass and the rest on a second pass.
ClotHound uses two manually expandable spheres that open 3 to 16 mm, independently of each other. The near sphere can slide 5cm back-and-forth along the shaft to loosen clot, and the far sphere is fixed to provide embolic protection downstream.
The study asked whether opening and moving these spheres injures the inner lining (intima) of arteries and veins. It tested the first-generation device and the second-generation, design-freeze device.


Angiograms after the device was used showed no significant damage to the lining
of the veins or arteries. Under the microscope vessel wall integrity was intact and
tissue looked essentially normal with no significant inflammation. Some samples
showed small areas of lost lining that the pathologist described as artifact,
without inflammation or bleeding.
In the lung-artery clot model, the first pig had complete clot removal without
vessel damage. In the second. about 80% of the clot came out on the first pass
and a second pass removed the rest.

Preview the first page below, or download the PDF (4 pages, about 1 MB).
The 74F aspiration /guide catheter (7.1 mm ID) tracked through serial 90-180 degree turns, with no lumen collapse at a 6 mm radius of curvature.
Maximum radial force from the wire sphere was 22 N, far below the force reported to rupture the saphenous vein and pulmonary artery.
A gravity-fed three-filter system removed 100% of test particles from a blood analogue, at more than 500 cc per minute.
Filtered bovine thrombus left no residual clot, and filtered porcine and human blood showed no sign of red blood cell injury or change in clotting profile.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.